Quick Answer
KIORA PHARMACEUTICALS INC reported Operating Income of -$12.83 million for fiscal year 2025.
KIORA PHARMACEUTICALS INC Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$12.83M | -384.5% |
| 2024 | $4.51M | +135.8% |
| 2023 | -$12.59M | -2.3% |
| 2022 | -$12.31M | +13.5% |
| 2021 | -$14.24M | -73.3% |
| 2020 | -$8.21M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$794.4K | +77.9% | +66.8% |
| June 30, 2025 | -$2.40M | +5.8% | -2.8% |
| March 31, 2025 | -$2.33M | -117.6% | +35.3% |
| September 30, 2024 | -$3.60M | +39.1% | -41.5% |
| June 30, 2024 | -$2.54M | +3.3% | -119.2% |
| March 31, 2024 | $13.22M | +789.8% | +323.4% |
| September 30, 2023 | -$5.92M | -59.8% | -124.8% |
| June 30, 2023 | -$2.63M | -9.6% | -37.4% |
- KIORA PHARMACEUTICALS INC showed a decrease of -384.5% in Operating Income compared to the prior fiscal year.
- Over the 2020–2025 period, KIORA PHARMACEUTICALS INC’s operating income has declined by 56.2% (from -$8.21 million to -$12.83 million).
- The most recent figure is from KIORA PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: